Related case:
TJD-AD 2021-003 Appeal Decision - Athletics
April 13, 2021
In December 2020 the Brazilian Doping Control Authority (ABCD) reported an anti-doping rule violation against the Athlete after her A and B samples tested positive for the prohibited substance Enobosarm (Ostarine) in a low concentration.
After notification a provisional suspension was ordered. The Athlete filed a statements in her defence and she was heard for the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD).
The Athlete explained with evidence that she had used supplement pills from a compounding pharmacy and she assumed that this supplement was the source of the prohibited substance.
The ABCD openend an investigation and analysis of the Athlete’s supplement pills in the Rio Lab revealed the presence of Ostarine as contamination including traces of the substances Canrenone and Spironolactone.
Futher the compounding pharmacy in question confirmed that on the same day that the Athlete's pills were compounded the substance Ostarine was compounded for another customer.
In view of the evidence the TJD-AD Rapporteur accepts that the Athlete’s anti-doping rule violation was not intentional and the result of the use of a contaminated supplement.
The Rapporteur regards that a low concentration Ostarine had been established in the Athlete’s samples, consistent with the contaminations found in the supplement pills. Further the Rapporteur considers that the Athlete acted with a light degree of Fault that justifies the imposition of a reduced sanction.
Therefore the TJD-AD Panel decides on 17 December 2020 to impose a 4 month period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 23 December 2020.
Finally the TJD-AD decides to request the Brazilian Health Regulatory Agency (Anvisa) in a complaint to impose measures against the compounding pharmacy in question because of the contaminations that had been established in supplements for athletes.
